A leading DTx co-dev partner.
Healthware Therapeutics' DTx partnerships are built upon an evolving pipeline of digital therapeutic solutions that give our partners an opportunity to jumpstart their digital health goals by licensing or co-investing in emerging DTx solutions. Our expertise is in core areas such as medical, technology, user design data and behavioral sciences, which contribute to our expanding DTx pipeline. Our assets consist of our proprietary DTx platform (H.Core), venture acquisitions and dynamic collaborations with innovative digital health startups.
Born and raised in Italy, then professionally baked in the US, Gerry Chillè is a unique multi-cultural individual with a polymorphous approach to problem solving and a true out-of-the-box thinker thanks to his extensive creative, technical and strategic background.
We are glad to share with you the second edition of the DIGITAL HEALTH NEWS & UPDATES booklet.
In January, we shared our ten predictions for 2022 in a webinar, along with key considerations for each. Here, we succinctly summarise these predictions, along with clear recommendations on how to act on the opportunity they present.
Jessica DaMassa caught up with Roberto Ascione, our CEO and Frontiers Health conference Chairman, about his newly released book